TuisENZN • OTCMKTS
add
Enzon Pharmaceuticals Inc
Vorige sluiting
$0,076
Dagwisseling
$0,075 - $0,082
Jaarwisseling
$0,060 - $0,24
Markkapitalisasie
6,09 m USD
Gemiddelde volume
17,02 k
P/V-verhouding
24,62
Dividend-opbrengs
-
Primêre beurs
OTCMKTS
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 351,00 k | 56,00% |
Netto inkomste | 254,00 k | -20,87% |
Netto winsgrens | — | — |
Wins per aandeel | — | — |
EBITDA | — | — |
Effektiewe belastingkoers | 16,17% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 46,63 m | 0,16% |
Totale bates | 47,28 m | 0,59% |
Totale aanspreeklikheid | 438,00 k | 7,88% |
Totale ekwiteit | 46,84 m | — |
Uitstaande aandele | 74,21 m | — |
Prys om te bespreek | 1,89 | — |
Opbrengs op bates | -1,86% | — |
Opbrengs op kapitaal | -1,88% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 254,00 k | -20,87% |
Kontant van bedrywe | 404,00 k | -5,16% |
Kontant van beleggings | — | — |
Kontant van finansiering | 0,00 | — |
Netto kontantverandering | 404,00 k | -5,16% |
Beskikbare kontantvloei | -119,38 k | -6,94% |
Meer oor
Enzon Pharmaceuticals, Inc. is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties. Wikipedia
Gestig
1981
Webwerf
